Montelukast Prescribing at TOWER HOUSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,234
Total Quantity
38.3K
NHS Cost
£1.9K
vs National Avg
+80.2%
TOWER HOUSE SURGERY prescribed 1,234 items of Montelukast over the last 12 months at a cost of £1,865 to the NHS. This is 80.2% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
115
Jun 2026
105
Jun 2026
110
Jun 2026
95
Jun 2026
103
Jun 2026
111
Jun 2026
91
Jun 2026
106
Jun 2026
97
Jun 2026
96
Jun 2026
104
Jun 2026
101
Prescribing Details
| Total Items | 1,234 |
|---|---|
| Total Quantity | 38,321 |
| Total NHS Cost | £1,865 |
| Presentations | 4 different forms |
| vs National Average | +80.2% |
Montelukast Prescribing Comparison
| This practice | 1,234 items |
|---|---|
| National average per practice | 685 items |
| Difference | +80.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.